Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ApoE epsilon3-haplotype modulates Alzheimer beta-amyloid deposition in the brain.
Myllykangas L, Polvikoski T, Reunanen K, Wavrant-De Vrieze F, Ellis C, Hernandez D, Sulkava R, Kontula K, Verkkoniemi A, Notkola IL, Hardy J, Perez-Tur J, Haltia MJ, Tienari PJ. Myllykangas L, et al. Am J Med Genet. 2002 Apr 8;114(3):288-91. doi: 10.1002/ajmg.10202. Am J Med Genet. 2002. PMID: 11920850
Alzheimer disease PS-1 exon 9 deletion defined.
Prihar G, Verkkoniem A, Perez-Tur J, Crook R, Lincoln S, Houlden H, Somer M, Paetau A, Kalimo H, Grover A, Myllykangas L, Hutton M, Hardy J, Haltia M. Prihar G, et al. Among authors: myllykangas l. Nat Med. 1999 Oct;5(10):1090. doi: 10.1038/13383. Nat Med. 1999. PMID: 10502791 No abstract available.
No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease.
Baker M, Graff-Radford D, Wavrant DeVrièze F, Graff-Radford N, Petersen RC, Kokmen E, Boeve B, Myllykangas L, Polvikoski T, Sulkava R, Verkoniemmi A, Tienari P, Haltia M, Hardy J, Hutton M, Perez-Tur J. Baker M, et al. Among authors: myllykangas l. Neurosci Lett. 2000 May 12;285(2):147-9. doi: 10.1016/s0304-3940(00)01057-0. Neurosci Lett. 2000. PMID: 10793248
Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
Lambert JC, Araria-Goumidi L, Myllykangas L, Ellis C, Wang JC, Bullido MJ, Harris JM, Artiga MJ, Hernandez D, Kwon JM, Frigard B, Petersen RC, Cumming AM, Pasquier F, Sastre I, Tienari PJ, Frank A, Sulkava R, Morris JC, St Clair D, Mann DM, Wavrant-DeVrièze F, Ezquerra-Trabalon M, Amouyel P, Hardy J, Haltia M, Valdivieso F, Goate AM, Pérez-Tur J, Lendon CL, Chartier-Harlin MC. Lambert JC, et al. Among authors: myllykangas l. Neurology. 2002 Jul 9;59(1):59-66. doi: 10.1212/wnl.59.1.59. Neurology. 2002. PMID: 12105308
99 results